Ownership Summary
A total of 8 institutions have reported a stake in Pharming Group N.V. (NASDAQ:PHAR) as of September 2025, according to recent 13F filings with the SEC.
- Institutional ownership in Pharming Group N.V edged down to 0.1% in September 2025, compared to 0.1% in June 2025.
- The company experienced a 0.40% quarterly change in institutional shares held, alongside an increase of 60.00% in total owners annually.
- Among the 8 institutional holders of Pharming Group N.V, 6 added to their stakes while 1 trimmed their positions and 1 held steady.
- Collectively, institutional investors increased their stake in Pharming Group N.V to 58.26K shares as of September 2025, a change that is up by 234 shares quarter on quarter and up 13.51K shares year over year.
- Silverberg Bernstein Capital Management LLC continues to be the largest institutional holder of Pharming Group N.V as of September 30, 2025, with a position of 52.15K shares, representing 0.06% of the company's outstanding stock.
- Among the most significant buyers of Pharming Group N.V during September 2025 were MORGAN STANLEY (1.46K), NewEdge Advisors, LLC (253), BNP PARIBAS FINANCIAL MARKETS (100), Global Retirement Partners, LLC (23), BESSEMER GROUP INC (3).
- Leading sellers of Pharming Group N.V stock in September 2025 included EverSource Wealth Advisors, LLC (1.60K).
- The top 8 institutional holders of Pharming Group N.V for the quarter ending September 2025 included Silverberg Bernstein Capital Management LLC (52.15K), MORGAN STANLEY (4.36K), EverSource Wealth Advisors, LLC (1.38K), NewEdge Advisors, LLC (253), BNP PARIBAS FINANCIAL MARKETS (100), Global Retirement Partners, LLC (23), BESSEMER GROUP INC (3), SBI Securities Co., Ltd. (2).